ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,126.40
-0.19%
S&P ASX All Technology
3,366.70
-1.47%
Brent Oil
73.395
-1.56%
US Dollar vs AUD
1.45497
0.47%
Bitcoin
63,760.23
-0.79%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aadi Bioscience Inc (AADI)

  7. Aadi Bioscience Inc (AADI) News

AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AADI
DateTimeSourceHeadlineSymbolCompany
20/09/202406:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
06/09/202407:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
04/09/202407:51Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AADIAadi Bioscience Inc
04/09/202400:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
23/08/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
21/08/202411:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
21/08/202407:00PR Newswire (US)Aadi Bioscience Provides PRECISION1 Trial and Corporate UpdatesNASDAQ:AADIAadi Bioscience Inc
08/08/202406:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AADIAadi Bioscience Inc
07/08/202422:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
07/08/202422:00PR Newswire (US)Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
06/08/202408:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
01/08/202406:05PR Newswire (US)Aadi Bioscience to Report Second Quarter 2024 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
15/06/202406:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
15/06/202406:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
15/06/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
15/06/202406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
15/06/202406:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
13/06/202406:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
06/06/202406:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
04/06/202402:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
30/05/202406:05PR Newswire (US)Aadi Bioscience to Participate in the Jefferies Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
24/05/202407:30PR Newswire (US)Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:AADIAadi Bioscience Inc
09/05/202406:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AADIAadi Bioscience Inc
08/05/202422:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
08/05/202422:00PR Newswire (US)Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
01/05/202422:01PR Newswire (US)Aadi Bioscience to Report First Quarter 2024 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
09/04/202422:00PR Newswire (US)Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:AADIAadi Bioscience Inc
17/03/202423:00PR Newswire (US)Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)NASDAQ:AADIAadi Bioscience Inc
13/03/202423:00PR Newswire (US)Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
07/03/202400:00PR Newswire (US)Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:AADI

Your Recent History

TG
SNW2
Sanofi
TG
A19UWU
Commonwealth Bank of Aus...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved